CAS 2702511-37-1

Fórmula: C21H27Cl3N2O3

InChI: InChI=1S/C21H25ClN2O3.2ClH/c22-19-9-5-4-8-18(19)21(17-6-2-1-3-7-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H

Chave InChI: MUZLUPGCGALIKR-UHFFFAOYSA-N

SMILES: C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=CC=C3Cl.Cl.Cl

Cetirizine Impurity C (dihydrochloride)

CAS: 2702511-37-1

Cetirizine Impurity C (dihydrochloride)

Fórmula: C₂₁H₂₇Cl₃N₂O₃

Pureza: 99%

Peso molecular: 461.81

Ref: 54-OR1133767

Cetirizine Impurity C (dihydrochloride)

CAS: 2702511-37-1

Pureza: 99%

Ref: IN-DA027JAD

Cetirizine Impurity C dihydrochloride

CAS: 2702511-37-1

Cetirizine Impurity C dihydrochloride is a Cetirizine metabolite and long-acting H1-antihistamine.

Fórmula: C₂₁H₂₇Cl₃N₂O₃

Cor e Forma: Solid

Peso molecular: 461.81

Ref: TM-T73962

(RS)-2-[2-[4-[(2-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride

Produto Controlado

CAS: 2702511-37-1

Fórmula: C₂₁H₂₅ClN₂O₃ClH

Cor e Forma: Neat

Peso molecular: 461.81

Ref: 86-MM0380.03

Cetirizine 2-Chloro Impurity Dihydrochloride

CAS: 2702511-37-1

Impurity Cetirizine EP Impurity C
Stability Hygroscopic
Applications Cetirizine (C281100) impurity as histamine inhibitor agent.
References Gengo, F.M., et al.: Clin. Pharmacol. Theraputics, 42, 265 (1987),

Fórmula: C₂₁H₂₅ClN₂O₃·2HCl

Cor e Forma: Neat

Peso molecular: 461.81

Ref: TR-C364840